However, AK7-mediated Sirt2 inhibition showed no therapeutic efficacy in mouse models of amyotrophic lateral sclerosis and ischemic stroke [152], indicating that Sirt2 inhibition only mitigates the pathophysiology of specific neurodegenerative diseases. This evidence concerns the gene SIRT2 and amyotrophic lateral sclerosis.